Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ANGANY Logo
ANGANY Growth Score
75
CB Rank
551218
Heat Score
40
ANGANY is a pharmaceutical company that offers treatment for allergies.
Founded
obfuscation
Private Quebec, Quebec, Canada11-50 angany.com
Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

ANGANY
Growth Score
75
Heat Score
40

Growth Score75
-4 pts
in past quarter
Heat Score 40
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ANGANY

CB Rank
551218
ANGANY is a pharmaceutical company that offers treatment for allergies.
Founded
obfuscation
Private Quebec, Quebec, Canada11-50 angany.com
Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical

Key People

Details

Legal Name Angany Inc.
Operating Status Active
Company Type For Profit
Phone Number 33-232590580
Contact Email veronique.gomord@anganygenetics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

ANG-101
A therapeutic vaccine candidate designed to treat cat allergy by restoring immune tolerance to the allergen Fel d 1.
eBioparticle™ Platform
A synthetic biology-based platform producing virus-like bioparticles that present allergens to remodel immune responses and restore immune tolerance.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 6

Employee Profiles

News

News and Press

News•Jan 29, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 2, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 5, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 10, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$79.8KThis year, ANGANY is projected to spend $79.8K on IT, according to Aberdeen.

Active Website Tech Count

4ANGANY is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Euro, and  CPanel.

Total IP

4The intellectual property of ANGANY includes 4 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ANGANY's headquarters? ANGANY is located in Quebec, Quebec, Canada.Who are ANGANY's competitors? Alternatives and possible competitors to ANGANY may include Alladapt Immunotherapeutics, DBV Technologies, and  Aimmune Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|